Price T Rowe Associates Inc Vericel Corp Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Vericel Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 29,479 shares of VCEL stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,479
Previous 30,347
2.86%
Holding current value
$1.16 Million
Previous $1.28 Million
26.19%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
49.5MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$318 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$137 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$128 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$94.8 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$88.2 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.86B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...